DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation
Status:
Completed
Trial end date:
2021-04-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn if taking a drug called direct oral anticoagulant after
an ablation procedure keeps blood clots from forming and lowers the chance of having a stroke
in patients with ventricular tachycardia or arrhythmia (VT).
Phase:
Phase 4
Details
Lead Sponsor:
Dhanunjaya Lakkireddy, MD, FACC Kansas City Heart Rhythm Institute
Collaborators:
Bristol-Myers Squibb Kansas City Heart Rhythm Research Foundation